News / Press Releases

: Press Releases

Press Releases

Tonix Pharmaceuticals Prices Public Offering of 1,800,000 Shares of Common Stock

March 30, 2017 • 8:01 AM EDT

Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock

March 29, 2017 • 4:07 PM EDT

Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at The MicroCap Conference

March 29, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Enrolls First Participant in Military-Related PTSD Phase 3 Trial of FDA Breakthrough Therapy-Designated TNX-102 SL

March 28, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split

March 16, 2017 • 1:00 PM EDT

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program at Oppenheimer’s 27th Annual Healthcare Conference

March 15, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent Covering Composition and Manufacture of TNX-102 SL

March 14, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 29th Annual ROTH Conference

March 7, 2017 • 7:00 AM EST

Tonix Pharmaceuticals Announces Demonstrated Vaccine Activity in First-Ever Synthesized Chimeric Horsepox Virus

March 2, 2017 • 7:24 AM EST

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the Cowen and Company 37th Annual Health Care Conference

February 28, 2017 • 7:00 AM EST

« Previous
1...
4
5
6
7
8
9
10
11
12
13
...27
Next »

Show All